What is Achieve Life Sciences Inc (ACHV) stock price today?

Achieve Life Sciences Inc (ACHV) currently trades at $4.15 per share. The stock has a market capitalization of $220.95M and a P/E ratio of —x.

Is ACHV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Achieve Life Sciences Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -10.51.

Is Achieve Life Sciences Inc financially healthy?

Achieve Life Sciences Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -10.51 places it in the distress.

ACHV

Achieve Life Sciences Inc

NASDAQ: ACHV · HEALTHCARE · BIOTECHNOLOGY

$4.15

-2.81% today

Updated 2026-04-29

Market cap

$220.95M

P/E ratio

—

P/S ratio

5.09x

EPS (TTM)

$-1.25

Dividend yield

—

52W range

$2 – $6

Volume

1.1M

Market cap

$220.95M

P/E ratio

—

P/S ratio

5.09x

EPS (TTM)

$-1.25

Dividend yield

—

52W range

$2 – $6

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

4.0

Valuation

3/9

Piotroski F-Score

Weak

-10.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$14.56

+250.84%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.30x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -10.51 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-17.98M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-41.88M	$-29.82M	$-39.83M	$-54.65M	$-14.66M
EPS	—	—	—	—	$-1.25
Free cash flow	$-37.57M	$-24.50M	$-29.77M	$-49.47M	$-17.98M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ACHV	$220.95M	26	4.3	3.0	4.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Achieve Life Sciences Inc trades at $4.15. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -10.51, it sits in the distress.

Frequently asked questions

What is Achieve Life Sciences Inc's stock price?

Achieve Life Sciences Inc (ACHV) trades at $4.15.

Is Achieve Life Sciences Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Achieve Life Sciences Inc (ACHV)?

The analyst target price is $14.56, representing +250.8% upside from the current price of $4.15.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-10.51 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio5.09x

ROE-257.70%

Beta1.96

50D MA$3.94

200D MA$3.91

Shares out0.05B

Float0.04B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ACHV vs LLY →ACHV vs JNJ →ACHV vs ABBV →Stock screener →